AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 89 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $92,347 | -3.1% | 11,616 | -3.5% | 0.00% | 0.0% |
| Q1 2021 | $95,349 | -12.4% | 12,039 | -12.9% | 0.00% | -50.0% |
| Q4 2020 | $108,803 | +11.0% | 13,825 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $98,019 | -23.8% | 13,825 | -0.5% | 0.00% | 0.0% |
| Q2 2020 | $128,584 | +62.9% | 13,901 | +35.4% | 0.00% | +100.0% |
| Q3 2019 | $78,938 | – | 10,265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 524,929 | $2,588,000 | 6.20% |
| DAFNA Capital Management LLC | 349,592 | $1,723,000 | 1.07% |
| Nantahala Capital Management | 1,602,903 | $7,902,000 | 0.39% |
| Sio Capital Management, LLC | 129,583 | $639,000 | 0.33% |
| Rock Springs Capital Management LP | 524,089 | $2,584,000 | 0.12% |
| Orbimed Advisors | 1,469,524 | $7,244,000 | 0.07% |
| Baker Brothers Advisors | 1,137,872 | $5,609,000 | 0.04% |
| Lee Financial Co | 22,408 | $110,000 | 0.04% |
| Spark Investment Management LLC | 42,002 | $207,000 | 0.01% |
| JENNISON ASSOCIATES LLC | 1,385,067 | $6,565,000 | 0.01% |